The Phillies have a familiar offseason problem on their hands: they need outfield help, and they need it badly. If the big-ticket free agents prove too expensive, one name that could slide into the conversation is Masataka Yoshida, the Red Sox bat whose contract and fit make him a strange but workable option for Philadelphia.
Yoshida’s reputation was built in Japan long before he arrived in Boston. Across seven seasons in Nippon Professional Baseball, the Fukui native hit .327/.421/.539 with 133 home runs and only 300 strikeouts in 3,189 plate appearances. He was a four-time All-Star, won two batting titles and helped Orix capture the 2022 Japan Series.
Boston paid for that track record in a big way. Before the 2023 season, the Red Sox gave Yoshida a five-year, $90 million deal and also paid a $15.375 million posting fee to the Buffaloes.
The expectation was obvious: a high-end hitter. What they’ve gotten instead has been a solid player who has been limited by injuries and defensive restrictions.
Yoshida’s first four seasons in the majors have been uneven. He played 140 games as a rookie, then dropped to 108 in 2024 before appearing in only 55 and 87 games in 2025 and 2026.
Even with the missed time, he has still produced when available, batting .280/.339/.420 with 119 extra-base hits in 1,503 plate appearances. The bigger issue is that he has barely been able to play the field, appearing in fewer than 10 games on the outfield grass in each of the last three seasons.
That’s where the Phillies’ roster mess comes in. Brandon Marsh made the All-Star team after a scorching first half in left field, then cratered late.
Justin Crawford was just okay in center and split time with Derek Hill. Right field was a disaster, with Adolis García putting up a sub-.600 OPS before season-ending surgery in June.
Gabriel Rincones Jr. struggled in his first big-league look, and Bryce Harper even had to move into the outfield to help finish the year.
Philadelphia needs at least one real outfielder next season, and there’s a case for two. But with a massive payroll and limited trade ammo, the club may have to get creative.
One possible path starts with the way Dave Dombrowski described the lineup in his year-end press conference. He said Harper will go back to being the club’s primary first baseman, though he could still see some outfield work if that helps the team. Dombrowski also said Kyle Schwarber is expected to play around 30 games at first base, which would free up more designated hitter at-bats.
That setup is awkward, but it creates a lane for Yoshida. On days Schwarber is at first, Yoshida could handle DH.
When Harper is at first and Schwarber is the DH, Yoshida could get some time in left field or simply serve as a very expensive bench bat. If Harper or Schwarber gets hurt, Yoshida could step right into the lineup.
It is not a perfect fit. But it may be the best kind of imperfect option available to the Phillies.
Randy Arozarena and Seiya Suzuki would be cleaner answers, but both are expected to land nine-figure deals and both come with qualifying offers attached. That makes the money question a real one for principal owner John Middleton. Yoshida, by contrast, could be cheaper to acquire if Philadelphia is willing to absorb part of the contract.
There’s also a business angle here. The Phillies have tried to break through in Japan before, most notably with a bid of more than $300 million for Yoshinobu Yamamoto. Adding Yoshida, who reportedly adores Bryce Harper, would at least give the organization a foothold in the Asian market and perhaps help with future pursuits.
Boston’s motivation is easier to see. Yoshida has not become the superstar the Red Sox imagined, and their outfield is crowded.
Ceddanne Rafaela just won a Gold Glove in center, Wilyer Abreu has two of his own in right, Jarren Duran is coming off a lost season but has been an MVP candidate before, and Roman Anthony is already in the mix after signing a nine-figure extension at age 22. That leaves little room for a bat with defensive limitations and a hefty salary.
For the Red Sox, moving Yoshida would clear money for another need. For the Phillies, taking on some of that deal could be the price of fixing a glaring weakness.
Philadelphia does not have the luxury of being picky right now. If Yoshida can help patch left field, DH and the bench while nudging the roster closer to a title run, he belongs on the list.
In Other News...
Phillies Just Added A Rotation Depth Arm With Something To Prove
The Phillies added another arm to the mix by signing right-hander Max Kranick to a minor league deal with a non-roster, split contract. It is the kind of move that rarely makes a splash on its own, but for a club that is always looking to protect its pitching depth, it fits the profile of a low-risk addition with a clear path to opportunity.
Kranick has pitched parts of four major league seasons and is expected to compete for a starting role, which gives this signing a little more intrigue than a typical camp invite. For Philadelphia, it is a depth play first and foremost, but for Kranick it is also a chance to make a case for more than just organizational insurance. [Read more 🡒]
Phillies Take Another Low-Risk Pitching Flier As Rotation Questions Linger
The Phillies have added another arm to the mix, reportedly agreeing to a minor-league deal with Max Kranick that includes a non-roster invitation to Major League spring training. Kranick has spent most of his recent seasons working out of the bullpen, and his arrival gives Philadelphia another low-cost look at a pitcher who could help fill out the staff if things break right.
It is the kind of move that fits the current moment for the Phillies, who are still expected to keep searching for ways to strengthen the rotation before the offseason is over. For Kranick, the path is straightforward enough: show enough in camp to stay in the conversation for a depth job, while the club continues sorting through bigger questions higher up on the pitching chart. [Read more 🡒]
Phillies Bullpen Plans Just Got Murkier Around Brad Keller
Brad Kellers first season in Philadelphia ended with a lot more uncertainty than the Phillies probably expected when they made him their highest-paid reliever. After working in 32 games and putting together a 4.02 ERA with 32 strikeouts, Keller had elbow surgery on July 29, and the recovery window alone has already pushed this situation well beyond a normal bullpen injury storyline.
Dave Dombrowski said the right-hander is expected to be available after the 2027 trade deadline, but even that comes with some uncertainty attached. For a Phillies bullpen that had hoped Keller would be a stabilizing piece, the bigger question now is how long the club will have to plan without him and what the relief mix looks like while his comeback remains on the far side of next summer. [Read more 🡒]
